Risk of Recurrence and Cancer Stem Cell Marker CD133 Expression Vary in Males Versus Females with Papillary Thyroid Cancer
A clear role of CD133 in prognostication has not been defined to date. Expression of CD133 and its association with survival varies between males and females, with stratification of recurrence risk more prominent in males.
Authors
- Andy D. Tran (ORCID: https://orcid.org/0000-0002-2388-7121)
- Anand Rajan (ORCID: https://orcid.org/0000-0002-6368-5217)
- Anna C. Beck (ORCID: https://orcid.org/0000-0003-0592-9540)
- Ronald J. Weigel (ORCID: https://orcid.org/0000-0002-9249-0793)
- Eyas Alzayadneh (ORCID: https://orcid.org/0000-0002-8521-300X)
- Jeremy Chang (ORCID: https://orcid.org/0000-0003-4692-5052)
Institutions
- University of Wisconsin–Madison (US)
- University of Iowa Hospitals and Clinics (US)
- University of Virginia (US)
Publication Details
- Journal
- Annals of Surgical Oncology
- Published
- 2025-04-11
- DOI
- https://doi.org/10.1245/s10434-025-17256-2
- Primary Topic
- Thyroid Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00